Literature DB >> 11996421

Assessing oral malignancies.

Mea A Weinberg1, Denise J Estefan.   

Abstract

Oral cancers account for approximately 3 percent of all cases of cancer in the United States. An estimated 30,000 people will be diagnosed with oral cancer this year, and about one half of them will eventually die of the disease. The most common type of oral cancer is squamous cell carcinoma. Sixty percent of oral cancers are well advanced by the time they are detected, even though physicians and dentists frequently examine the oral cavity. The two most important risk factors for oral cancer are tobacco use and heavy alcohol consumption. The keys to reducing mortality are prevention and control. The earlier any intraoral or extraoral abnormalities or lesions are detected and biopsied, the more lives can be saved. Controversy exists whether screening programs effectively reduce the mortality rate. Specific step-by-step guidelines should be followed to perform an adequate examination of the head and neck.

Entities:  

Mesh:

Year:  2002        PMID: 11996421

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  10 in total

1.  Oral cancer awareness among undergraduate dental students in Iran.

Authors:  Graham R Ogden; Nima Mahboobi
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

2.  Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma.

Authors:  Kentaro Sakuma; Atsushi Kasamatsu; Masanobu Yamatoji; Yukio Yamano; Kazuaki Fushimi; Manabu Iyoda; Kenji Ogoshi; Keiji Shinozuka; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-27       Impact factor: 4.553

3.  Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.

Authors:  Elizabeth J Franzmann; Erika P Reategui; Lutecia H Mateus Pereira; Felipe Pedroso; Debbie Joseph; Glenn O Allen; Kara Hamilton; Isildinha Reis; Robert Duncan; W Jarrard Goodwin; Jennifer J Hu; Vinata B Lokeshwar
Journal:  Head Neck       Date:  2011-07-11       Impact factor: 3.147

4.  Assessing Oral Cancer Awareness Among Dental Students.

Authors:  Gaye Keser; Filiz Namdar Pekiner
Journal:  J Cancer Educ       Date:  2019-06       Impact factor: 2.037

5.  Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).

Authors:  Carsten Sticht; Kolja Freier; Karl Knöpfle; Christa Flechtenmacher; Susanne Pungs; Christof Hofele; Meinhard Hahn; Stefan Joos; Peter Lichter
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

Review 6.  Paying more than lip service to lip lesions.

Authors:  Janna M Bentley; Benjamin Barankin; Gilles J Lauzon
Journal:  Can Fam Physician       Date:  2003-09       Impact factor: 3.275

Review 7.  Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.

Authors:  Giovana Calixto; Jéssica Bernegossi; Bruno Fonseca-Santos; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2014-08-08

8.  A primary tumor gene expression signature identifies a crucial role played by tumor stroma myofibroblasts in lymph node involvement in oral squamous cell carcinoma.

Authors:  Tommaso Mazza; Lorenzo Lo Muzio; Gianluigi Mazzoccoli; Stefano Castellana; Massimo Carella; Orazio Palumbo; Cristiana Tiberio; Caterina Fusilli; Daniele Capocefalo; Tommaso Biagini
Journal:  Oncotarget       Date:  2017-09-05

9.  Screening Projects for Oral Carcinoma in Relation to Health Education and Patients' Compliance: Study on 600 Participants.

Authors:  Stefania Leuci; Massimo Amato; Elena Calabria; Gianrico Spagnuolo; Michele Masucci; Michele Mignogna Davide
Journal:  J Int Soc Prev Community Dent       Date:  2017-11-30

10.  Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.

Authors:  Lin Lin; Jiayi Wang; Dongjuan Liu; Sai Liu; Hao Xu; Ning Ji; Min Zhou; Xin Zeng; Dunfang Zhang; Jing Li; Qianming Chen
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.